“Probably in response to its failure to avoid the increase in prescription opioid misuse, the D.E.A. could be endeavoring to avert a repeat crisis by maintaining stimulant manufacturing quotas limited,” Szalavitz https://philiprysf749340.blogdigy.com/latest-news-on-adderall-an-overview-45029560